SINGAPORE: The Government of Singapore Investment Corp (GIC) has raised US$1.25 billion by selling about 596 million shares in warehouse operator Global Logistic Properties (GLP).
GIC sold the shares at S$2.60 each, which is a 4.8 per cent discount to Monday's closing price.
Following the share sale, it now holds a 37 per cent stake in GLP, down from 49 per cent.
GIC said the move is part of the fund's portfolio rebalancing and it will remain a substantial shareholder for the long run.
- CNA/ms
The National Investigation Agency (NIA) moved a plea before district judge I S Mehta, who issued production warrants for Wednesday against Syed Maqbool and Imran Khan.
The two are lodged in Tihar Jail under judicial custody after being arrested by the Special Cell of Delhi Police in connection with the August 2012 Pune blasts.
The court has directed the Tihar Jail authorities to produce both the alleged IM operatives before it tomorrow when it will hear the NIA's plea seeking their custodial interrogation.
According to NIA, Maqbool and Imran had in July, 2012 allegedly recced Hyderabad's Dilsukhnagar, where the blasts took place, on the instructions of IM's Pakistan-based founder Riyaz Bhatkal and their interrogation will help them to know the exact plan envisaged by Riyaz.
NIA prosecutor Ahmed Khan said they require the custody of the duo to interrogate them regarding the recent Hyderabad blasts as they are suspected operatives of IM and could give them details and more clues about the executors of the blasts.
On February 21, Hyderabad was rocked by two blasts in the crowded Dilsukhnagar area.
The blasts triggered by improvised explosive devices (IED) took place outside a roadside eatery near Konark and Venkatadiri theatres in the area.
With his striking beard and starched uniform, former Surgeon General Dr. C. Everett Koop became one of the most recognizable figures of the Reagan era — and one of the most unexpectedly enduring.
His nomination in 1981 met a wall of opposition from women's groups and liberal politicians, who complained President Ronald Reagan selected Koop, a pediatric surgeon and evangelical Christian from Philadelphia, only because of his conservative views, especially his staunch opposition to abortion.
Soon, though, he was a hero to AIDS activists, who chanted "Koop, Koop" at his appearances but booed other officials. And when he left his post in 1989, he left behind a landscape where AIDS was a top research and educational priority, smoking was considered a public health hazard, and access to abortion remained largely intact.
Koop, who turned his once-obscure post into a bully pulpit for seven years during the Reagan and George H.W. Bush administrations and who surprised both ends of the political spectrum by setting aside his conservative personal views on issues such as homosexuality and abortion to keep his focus sharply medical, died Monday at his home in Hanover, N.H. He was 96.
An assistant at Koop's Dartmouth College institute, Susan Wills, confirmed his death but didn't disclose its cause.
Dr. Richard Carmona, who served as surgeon general a decade ago under President George W. Bush, said Koop was a mentor to him and preached the importance of staying true to the science even if it made politicians uncomfortable.
"He set the bar high for all who followed in his footsteps," Carmona said.
Although the surgeon general has no real authority to set government policy, Koop described himself as "the health conscience of the country" and said modestly just before leaving his post that "my only influence was through moral suasion."
A former pipe smoker, Koop carried out a crusade to end smoking in the United States; his goal had been to do so by 2000. He said cigarettes were as addictive as heroin and cocaine. And he shocked his conservative supporters when he endorsed condoms and sex education to stop the spread of AIDS.
Chris Collins, a vice president of amFAR, the Foundation for AIDS Research, said many people don't realize what an important role Koop played in the beginning of the AIDS epidemic.
"At the time, he really changed the national conversation, and he showed real courage in pursuing the duties of his job," Collins said.
Even after leaving office, Koop continued to promote public health causes, from preventing childhood accidents to better training for doctors.
"I will use the written word, the spoken word and whatever I can in the electronic media to deliver health messages to this country as long as people will listen," he promised.
In 1996, he rapped Republican presidential hopeful Bob Dole for suggesting that tobacco was not invariably addictive, saying Dole's comments "either exposed his abysmal lack of knowledge of nicotine addiction or his blind support of the tobacco industry."
Although Koop eventually won wide respect with his blend of old-fashioned values, pragmatism and empathy, his nomination met staunch opposition.
Foes noted that Koop traveled the country in 1979 and 1980 giving speeches that predicted a progression "from liberalized abortion to infanticide to passive euthanasia to active euthanasia, indeed to the very beginnings of the political climate that led to Auschwitz, Dachau and Belsen."
But Koop, a devout Presbyterian, was confirmed after he told a Senate panel he would not use the surgeon general's post to promote his religious ideology. He kept his word.
In 1986, he issued a frank report on AIDS, urging the use of condoms for "safe sex" and advocating sex education as early as third grade.
He also maneuvered around uncooperative Reagan administration officials in 1988 to send an educational AIDS pamphlet to more than 100 million U.S. households, the largest public health mailing ever.
Koop personally opposed homosexuality and believed sex should be saved for marriage. But he insisted that Americans, especially young people, must not die because they were deprived of explicit information about how HIV was transmitted.
Koop further angered conservatives by refusing to issue a report requested by the Reagan White House, saying he could not find enough scientific evidence to determine whether abortion has harmful psychological effects on women.
Koop maintained his personal opposition to abortion, however. After he left office, he told medical students it violated their Hippocratic oath. In 2009, he wrote to Senate Majority Leader Harry Reid, urging that health care legislation include a provision to ensure doctors and medical students would not be forced to perform abortions. The letter briefly set off a security scare because it was hand delivered.
Koop served as chairman of the National Safe Kids Campaign and as an adviser to President Bill Clinton's health care reform plan.
At a congressional hearing in 2007, Koop spoke about political pressure on the surgeon general post. He said Reagan was pressed to fire him every day, but Reagan would not interfere.
Koop, worried that medicine had lost old-fashioned caring and personal relationships between doctors and patients, opened his institute at Dartmouth to teach medical students basic values and ethics. He also was a part-owner of a short-lived venture, drkoop.com, to provide consumer health care information via the Internet.
Koop was born in the New York City borough of Brooklyn, the only son of a Manhattan banker and the nephew of a doctor. He said by age 5 he knew he wanted to be a surgeon and at age 13 he practiced his skills on neighborhood cats.
He attended Dartmouth, where he received the nickname Chick, short for "chicken Koop." It stuck for life.
Koop received his medical degree at Cornell Medical College, choosing pediatric surgery because so few surgeons practiced it.
In 1938, he married Elizabeth Flanagan, the daughter of a Connecticut doctor. They had four children, one of whom died in a mountain climbing accident when he was 20.
Koop was appointed surgeon-in-chief at Children's Hospital in Philadelphia and served as a professor at the University of Pennsylvania School of Medicine.
He pioneered surgery on newborns and successfully separated three sets of conjoined twins. He won national acclaim by reconstructing the chest of a baby born with the heart outside the body.
Although raised as a Baptist, he was drawn to a Presbyterian church near the hospital, where he developed an abiding faith. He began praying at the bedside of his young patients — ignoring the snickers of some of his colleagues.
Koop's wife died in 2007, and he married Cora Hogue in 2010.
He was by far the best-known surgeon general and for decades afterward was still a recognized personality.
"I was walking down the street with him one time" about five years ago, recalled Dr. George Wohlreich, director of the College of Physicians of Philadelphia, a medical society with which Koop had longstanding ties. "People were yelling out, 'There goes Dr. Koop!' You'd have thought he was a rock star."
___
Ring reported from Montpelier, Vt. Cass reported from Washington. AP Medical Writers Lauran Neergaard in Washington and Mike Stobbe in New York contributed to this report.
Arthur Benjamin is sitting at the edge of a small stage, wearing a lavender Hawaiian shirt and nursing a bottle of San Miguel Light beer. The 6-foot-6 mustachioed Texan lazily watches the half dozen or so girls dancing rather unenergetically around the stage's pole.
"I forgot your gift again, it's in the car," Benjamin says to one of the girls on stage, shouting above the pop music blaring from the speaker system.
The small, dingy bar, which Benjamin says he owns, is called Crow Bar. It's in a rundown part of the picturesque Subic Bay in the western Philippines, about a three hour drive from the capital, Manila. Home for 50 years to a United States naval base, Subic Bay has become synonymous with foreigners looking for sex in the long string of bars that line the main road along the coast.
Watch the full story on "Nightline" TONIGHT at 12:35 a.m. ET
The bars in this area are often packed with older foreign men ogling the young Filipina women available for the night for a "bar fine" of around 1,500 Filipino pesos, or just over $35. Many of the bars are owned and operated by Americans, often former military servicemen who either served on the base or whose ships docked here until the base was shuttered under political pressure in 1992.
Most of the prostitutes working in the bars are indeed 18 or older. But in the Philippines, just a small scratch to the surface can reveal a layer of young, underage girls who have mostly come from impoverished rural provinces to sell their bodies to help support their families.
Benjamin, 49, is, according to his own statements, one of the countless foreigners who has moved beyond just having sex with underage girls to owning and operating a bar where girls in scantily-clad outfits flaunt their bodies for patrons.
"My wife recently found out that I have this place," he tells an ABC News "Nightline" team, unaware they are journalists and recording the conversation on tiny hidden cameras disguised as shirt buttons.
Benjamin said that a "disgruntled waitress" had written his wife on Facebook, detailing his activities in Subic Bay.
"She sent her this thing saying that I have underage girls who stayed with me, that I [have anal sex with them], I own a bar, I've got other girls that I'm putting through high school, all this other crap," he said.
"All of which is true," he laughed. "However, I have to deny."
He sends a text message summoning his current girlfriend, a petite dark-skinned girl called Jade, who he said is just 16 years old. Benjamin says he bought the bar for her about a year ago and while most still call it Crow Bar, he officially re-named it with her last name.
"She needed a place to stay, I needed a place to do her. I bought a bar for her," he says, explaining that she lives in a house out back by the beach.
"You're not going to find anything like this in the States, not as a guy my age," he said as he looked down at Jade. "Ain't going to happen."
Benjamin is the latest target of Father Shay Cullen, a Catholic priest with a thick Irish brogue and fluency in the local language, Tagalog. Through his non-profit center called Preda, he's been crusading against underage sex trafficking in the Philippines for 40 years.
SINGAPORE: The government has introduced a slew of measures to help Singaporeans cope with the rising cost of living.
These measures include income tax rebates, extra GST voucher and Service & Conservancy Charges rebates.
Taxpayers who are 60 years and above will enjoy a higher income tax rebate of 50 per cent, capped at S$1,500.
Those who are below 60 years old will get a rebate of 30 per cent, which is also capped at S$1,500.
These measures were announced by Deputy Prime Minister in his Budget Statement on Monday.
Singaporeans will also get an extra one-off GST voucher on top of the permanent voucher.
The government will give rebates of one to three months for Service & Conservancy Charges.
One- and two-room HDB households will receive three months of rebates for 2013, while three- and four-room households will get two months of rebates.
The concessionary foreign domestic worker levy will be lowered for families with young children, elderly dependents and persons with disabilities.
The levy will be reduced from S$170 to S$120 per month.
- CNA/fa
A division bench comprising Justices K T Shankaran and M L Joseph Francis said the appeal and records about the case had not been received from the Supreme Court and it cannot proceed without perusing them, even though the accused wanted their pleas to be taken up today.
According to the accused, the apex court had not gone into the merits of the case and judgement was on technical grounds. The accused, who had been convicted and sentenced by the sessions court, are among the 35 acquitted by a division bench of the high court in 2005.
However, the Supreme Court had however recently set aside the acquittals and asked them to surrender before the special court hearing the case.
First accused Rajan and fifth accused Cherian are among those who have moved for bail maintaining there was no material against them to prove the charges.
Dharmarajan, the third accused, who had jumped bail, had recently been arrested from Karnataka and sent to jail. The high court had reduced his life term to five years. Following the Supreme Court judgement, Dharmarajan has to undergo the rest of his prison term.
The case relates to a 16-year-old girl who was abducted in 1996 and taken to to various places and sexually exploited.
Kurien was acquitted but the victim had recently named him as one of those who allegedly assaulted her in 1996.
The victim had also sent a letter to her advocate seeking to explore the possibility of filing a review plea in the Supreme Court for a fresh probe against Kurien, who according to the victim, had raped her at the Kumily guest house on February 9, 1996.
Kurien has maintained that he had been cleared of the charges by the apex court.
WASHINGTON (AP) — The Food and Drug Administration has approved a first-of-a-kind breast cancer medication that targets tumor cells while sparing healthy ones.
The drug Kadcyla from Roche combines the established drug Herceptin with a powerful chemotherapy drug and a third chemical linking the medicines together. The chemical keeps the cocktail intact until it binds to a cancer cell, delivering a potent dose of anti-tumor poison.
Cancer researchers say the drug is an important step forward because it delivers more medication while reducing the unpleasant side effects of chemotherapy.
"This antibody goes seeking out the tumor cells, gets internalized and then explodes them from within. So it's very kind and gentle on the patients — there's no hair loss, no nausea, no vomiting," said Dr. Melody Cobleigh of Rush University Medical Center. "It's a revolutionary way of treating cancer."
Cobleigh helped conduct the key studies of the drug at the Chicago facility.
The FDA approved the new treatment for about 20 percent of breast cancer patients with a form of the disease that is typically more aggressive and less responsive to hormone therapy. These patients have tumors that overproduce a protein known as HER-2. Breast cancer is the second most deadly form of cancer in U.S. women, and is expected to kill more than 39,000 Americans this year, according to the National Cancer Institute.
The approval will help Roche's Genentech unit build on the blockbuster success of Herceptin, which has long dominated the breast cancer marketplace. The drug had sales of roughly $6 billion last year.
Genentech said Friday that Kadcyla will cost $9,800 per month, compared to $4,500 per month for regular Herceptin. The company estimates a full course of Kadcyla, about nine months of medicine, will cost $94,000.
FDA scientists said they approved the drug based on company studies showing Kadcyla delayed the progression of breast cancer by several months. Researchers reported last year that patients treated with the drug lived 9.6 months before death or the spread of their disease, compared with a little more than six months for patients treated with two other standard drugs, Tykerb and Xeloda.
Overall, patients taking Kadcyla lived about 2.6 years, compared with 2 years for patients taking the other drugs.
FDA specifically approved the drug for patients with advanced breast cancer who have already been treated with Herceptin and taxane, a widely used chemotherapy drug. Doctors are not required to follow FDA prescribing guidelines, and cancer researchers say the drug could have great potential in patients with earlier forms of breast cancer
Kadcyla will carry a boxed warning, the most severe type, alerting doctors and patients that the drug can cause liver toxicity, heart problems and potentially death. The drug can also cause severe birth defects and should not be used by pregnant women.
Kadcyla was developed by South San Francisco-based Genentech using drug-binding technology licensed from Waltham, Mass.-based ImmunoGen. The company developed the chemical that keeps the drug cocktail together and is scheduled to receive a $10.5 million payment from Genentech on the FDA decision. The company will also receive additional royalties on the drug's sales.
Shares of ImmunoGen Inc. rose 2 cents to $14.32 in afternoon trading. The stock has ttraded in a 52-wek range of $10.85 to $18.10.
"Argo" took home the top prize as best picture at the Oscars Sunday night, with first lady Michelle Obama announcing the winner from the White House.
"You directed a hell of a film," co-producer Grant Heslov told director and fellow producer Ben Affleck. "I couldn't be more proud of the film and more proud of our director."
Affleck was snubbed in the directing category but humbly accepted the best picture Oscar as one of the three producers on the film. George Clooney was the third.
Affleck thanked Steven Spielberg and the other best picture nominees and his wife Jennifer Garner for "working on our marriage."
"It's good, it's work," he said, adding, "but there's no one I'd rather work with."
For Full List of Winners
Acknowledging his last Oscar win, as a screenwriter for "Good Will Hunting," Affleck said, "I was really just a kid. I never thought I would be back here."
In the acting categories, Daniel Day-Lewis won the Oscar for best actor, being the first actor to three-peat in that category. As he accepted the award from Hollywood's greatest actress, Meryl Streep, he joked, "I had actually been committed to play Margaret Thatcher. ... Meryl was Stephen's first choice for Lincoln."
He also thanked his wife, Rebecca Miller, for "living with some very strange men," with each new role that he takes on.
"She's the versatile one in the family and she's been the perfect companion to all of them," he said.
Kevin Winter/Getty Images
Jennifer Lawrence won the award for best actress. She tripped on the stairs on her way to accepting her award but picked herself up and made her way to the stage, earning a standing ovation.
"You're just standing up because you feel bad that I fell and that's embarrassing," she said, before rattling off a list of thank-yous and leaving the stage looking slightly stunned.
Watch Jennifer Lawrence's Oscar Tumble
"Life of Pi," which had a total of 11 nominations, was another big winner of the night. Director Ang Lee took home the Oscar for best director over Steven Spielberg and David O. Russell.
"Thank you, movie god," Lee said, accepting his award.
As expected, the film took home the first technical awards of the night for cinematography and visual effects. "Life of Pi" also won for best original score.
The first big acting awards of the night went to Christoph Waltz and Anne Hathaway in the supporting actor categories.
In one of the biggest tossups, Waltz claimed the award for supporting actor for his role in "Django Unchained." It was his second Oscar for a Quentin Tarantino film; his first was for Tarantino's "Inglourious Basterds."
PHOTOS: Stars on the Red Carpet
As expected, Hathaway took home the award for best supporting actress for her role as Fantine in "Les Miserables."
"It came true," she said, launching into a breathy speech, in which she thanked the cast and crew, her team and her husband. "The greatest moment of my life was when you walked into it," she said.
Tarantino won the Oscar for best original screenplay for his slave revenge western "Django Unchained." He thanked his cast.
"I have to cast the right people," he said. "And boy this time did I do it."
Chris Terrio won the award for best adapted screenplay for "Argo," which also won for film editing.
For only the sixth time in Academy history, there was a tie at the Oscars. "Zero Dark Thirty" and "Skyfall" tied for sound editing.
See Other Ties in Academy History
NEW DELHI: Indian Prime Minister Manmohan Singh on Sunday appealed for calm as he flew to Hyderabad and visited some of the 117 people wounded in twin bombings last week which killed 16 people.
Singh also visited the blast site in Dilsukh Nagar, where two bicycle bombs exploded within a few minutes of each other outside a cinema and near a bus stand on Thursday evening.
The prime minister met with some of the blast survivors and medical staff in two city hospitals and expressed his condolences.
"It is most important that in this hour of grief the people should maintain calm," he said.
"I am happy that the people of Hyderabad have refused to be provoked by this nefarious incident," the prime minister told reporters.
"I pray for the speedy recovery of those who have been injured, to those who have died I send my condolences to all the bereaved families," Singh added.
His spokesman Pankaj Pachauri told AFP Singh was scheduled to be briefed by N. Kiran Kumar Reddy, chief minister of the southern state of Andhra Pradesh, on the incident.
Hyderabad, one of the major hubs of India's booming software industry, is the capital of coastal Andhra Pradesh.
The premier has vowed to bring to justice the perpetrators of what he called a "dastardly" attack, the first major bombings in India since 2011.
His Congress Party-led government was criticised in parliament on Friday by the opposition, which said the bombings had exposed systemic security failures at a time when India is on heightened alert.
India's main opposition BJP party mocked the premier's one-day trip to Hyderabad saying the blasts were a result of the Indian government's failure to tackle terrorism.
"The prime minister's visit to Hyderabad is a non-event," BJP leader Balbir Punj told reporters in New Delhi.
"In fact, if he and his government had been sensitive to the issue of terrorism in this country... this attack would not have taken place," he said.
Andhra Pradesh Home Minister P. Sabita Indra Reddy has said investigators have found "vital clues" but gave no details.
Newspapers have pointed the finger at the Indian Mujahideen, a banned militant outfit which has claimed responsibility for previous attacks.
The fitting of the explosive devices to bicycles was similar to other attacks by the outfit, local media reports quoted investigators as saying.
The homegrown group has links to Lashkar-e-Taiba, the Pakistan-based militant outfit blamed for the 2008 Mumbai attacks that claimed 166 lives, according to Indian intelligence officials.
New Delhi has long accused its neighbour of aiding and abetting the militant groups who have carried out attacks on Indian soil -- a charge that Pakistan rejects.
- AFP/fa
WASHINGTON (AP) — The Food and Drug Administration has approved a first-of-a-kind breast cancer medication that targets tumor cells while sparing healthy ones.
The drug Kadcyla from Roche combines the established drug Herceptin with a powerful chemotherapy drug and a third chemical linking the medicines together. The chemical keeps the cocktail intact until it binds to a cancer cell, delivering a potent dose of anti-tumor poison.
Cancer researchers say the drug is an important step forward because it delivers more medication while reducing the unpleasant side effects of chemotherapy.
"This antibody goes seeking out the tumor cells, gets internalized and then explodes them from within. So it's very kind and gentle on the patients — there's no hair loss, no nausea, no vomiting," said Dr. Melody Cobleigh of Rush University Medical Center. "It's a revolutionary way of treating cancer."
Cobleigh helped conduct the key studies of the drug at the Chicago facility.
The FDA approved the new treatment for about 20 percent of breast cancer patients with a form of the disease that is typically more aggressive and less responsive to hormone therapy. These patients have tumors that overproduce a protein known as HER-2. Breast cancer is the second most deadly form of cancer in U.S. women, and is expected to kill more than 39,000 Americans this year, according to the National Cancer Institute.
The approval will help Roche's Genentech unit build on the blockbuster success of Herceptin, which has long dominated the breast cancer marketplace. The drug had sales of roughly $6 billion last year.
Genentech said Friday that Kadcyla will cost $9,800 per month, compared to $4,500 per month for regular Herceptin. The company estimates a full course of Kadcyla, about nine months of medicine, will cost $94,000.
FDA scientists said they approved the drug based on company studies showing Kadcyla delayed the progression of breast cancer by several months. Researchers reported last year that patients treated with the drug lived 9.6 months before death or the spread of their disease, compared with a little more than six months for patients treated with two other standard drugs, Tykerb and Xeloda.
Overall, patients taking Kadcyla lived about 2.6 years, compared with 2 years for patients taking the other drugs.
FDA specifically approved the drug for patients with advanced breast cancer who have already been treated with Herceptin and taxane, a widely used chemotherapy drug. Doctors are not required to follow FDA prescribing guidelines, and cancer researchers say the drug could have great potential in patients with earlier forms of breast cancer
Kadcyla will carry a boxed warning, the most severe type, alerting doctors and patients that the drug can cause liver toxicity, heart problems and potentially death. The drug can also cause severe birth defects and should not be used by pregnant women.
Kadcyla was developed by South San Francisco-based Genentech using drug-binding technology licensed from Waltham, Mass.-based ImmunoGen. The company developed the chemical that keeps the drug cocktail together and is scheduled to receive a $10.5 million payment from Genentech on the FDA decision. The company will also receive additional royalties on the drug's sales.
Shares of ImmunoGen Inc. rose 2 cents to $14.32 in afternoon trading. The stock has ttraded in a 52-wek range of $10.85 to $18.10.
Copyright © News inexistence. All rights reserved.
Design 
And Business Directories
